Literature DB >> 7901284

A comparison of the DNA fragment patterns of the mouse-virulent challenge strains and clinical isolates of Bordetella pertussis.

M N Khattak1, R C Matthews.   

Abstract

The DNA fragment patterns of two mouse-virulent strains of Bordetella pertussis, commonly used in animal protection tests, were compared to those of clinical isolates. Strain W.18-323 and six variants were examined together with strain 353/Z and two variants. Chromosomal DNA was digested with the rare-cutting enzyme Xba I in order to produce relatively large fragments resolved by pulsed-field gel electrophoresis. The resulting DNA fragment patterns of strain 353/Z and those of its variants were indistinguishable from those of the commonest DNA type among clinical isolates. In contrast, strain W.18-323 and its variants showed a distinct genetic type, different from clinical isolates of B. pertussis, B. parapertussis or B. bronchiseptica. This finding, together with some phenotypic anomalies of this strain, raises doubts as to the suitability of W.18-323 as a challenge strain for assessing the efficacy of vaccines in the mouse model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901284     DOI: 10.1016/0163-4453(93)94566-t

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.

Authors:  L Bassinet; P Gueirard; B Maitre; B Housset; P Gounon; N Guiso
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.

Authors:  Mark S Peppler; Sharee Kuny; Anna Nevesinjac; Christina Rogers; Yvon R de Moissac; Kathleen Knowles; Manon Lorange; Gaston De Serres; James Talbot
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  An epidemiological study of blood culture isolates of coagulase-negative staphylococci demonstrating hospital-acquired infection.

Authors:  J P Burnie; M Naderi-Nasab; K W Loudon; R C Matthews
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

6.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Authors:  E Grimprel; P Bégué; I Anjak; E Njamkepo; P François; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

7.  Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host.

Authors:  P Gueirard; C Weber; A Le Coustumier; N Guiso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.